Healthcare Industry News: Janssen
News Release - May 16, 2006
Wyeth Announces New Head of Corporate Diversity EffortMADISON, N.J., May 16 (HSMN NewsFeed) -- Wyeth (NYSE: WYE ) today announced the promotion of Dr. Daphne Mobley to the position of Vice President, Corporate Diversity. Dr. Mobley will provide strategic leadership for the Company's global diversity program and ensure programmatic alignment with Wyeth's business objectives. She will develop Wyeth's diversity goals that enhance established practices and ultimately result in the retention, recruitment and development of a diverse workforce.
The Company's diversity program will also include a communications strategy, establishment and maintenance of partnerships with diverse organizations, as well as a diversity awareness curriculum designed to increase employees' knowledge of diversity.
Dr. Mobley joined Wyeth in 1992 as Manager, Toxicology, Laboratory Animal Resources. In 2004, she was promoted to Assistant Vice President, Planning, reporting to Bob Essner, Wyeth's Chairman and Chief Executive Officer.
Dr. Mobley started her career at Janssen Research Foundation as a cardiovascular researcher. She received her Bachelor of Science degree in Animal Science from Cornell University and her Doctorate in Veterinary Medicine from the University of Florida.
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.